Combinations of CDK7i with other cancer therapeutics have also been explored, for example, BRD4 and CDK7i have been shown to work synergistically in neuroblastoma [37] and a combination of PARP and CDK7i show synergism for the treatment of Ewing Sarcoma [38]. This evidence concerns the gene BRD4 and cancer.